On the afternoon of April 18, 2024, Comrade Li Weidong, vice president of Chengdu Hospital of Integrated Chinese and Western Medicine and other 4 people visited the society for research and discussion, and talked about deepening cooperation. Chengdu High-tech Medical Association Vice President and Secretary-General Comrade Zeng Bin, Vice president and deputy Secretary-General Comrade Ai He, deputy secretary of the branch and office director Comrade Zhang Qili and other relevant departments in charge of 7 people attended the symposium.
At the symposium, Vice President Li Weidong and Secretary-General Zeng Bin respectively introduced the basic situation and current work progress
of the hospital and the society, and the two sides made good prospects for strengthening information sharing, integrating resources and deepening
cooperation. At the same time, in-depth exchanges were carried out on the promotion of discipline construction, academic exchanges, continuing
education, science popularization and health education, medical quality control, multi-party linkage to carry out scientific and technological innovation
and promote the development of biological industry, and recommend various professional experts to support the high-quality construction of regional
health industry.
Subsequently, the hospital leaders also looked forward to the future development plan of the hospital, including further improving the quality of medical
services, strengthening the construction of medical quality control center, promoting scientific research and innovation, and expanding foreign exchanges
and cooperation. The hospital will be committed to becoming a model in the field of integrated Chinese and Western medicine to provide more patients
with quality medical services.
双方交流现场
Finally, the two sides hope to move more, communicate more, contact and cooperate more closely, share the progress of work and problems encountered in a timely manner, and jointly negotiate solutions. Give full play to their respective advantages to deepen cooperation, continue to play the leading role of innovation drivers, and contribute to the high-quality development and innovation of regional medical undertakings.
